|
FY2025
12 months to Nov 30, 2025
|
FY2024
12 months to Nov 30, 2024
|
FY2023
12 months to Nov 30, 2023
|
FY2022
12 months to Nov 30, 2022
|
FY2021
12 months to Nov 30, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Collaboration revenue | |||||
| License revenue | |||||
| Total revenue | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest and other income, net | |||||
| Loss before income taxes | |||||
| Provision for income taxes | |||||
| Net loss | |||||
| Net loss per share, basic (in USD per share) | |||||
| Net loss per share, diluted (in USD per share) | |||||
| Weighted-average number of shares outstanding, basic (in shares) | |||||
| Weighted-average number of shares outstanding, diluted (in shares) | |||||
Loading...
